BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21518020)

  • 1. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.
    Kamiyama Y; Matsuura S; Kato M; Abe Y; Takyu S; Yoshikawa K; Arai Y
    Int J Urol; 2011 May; 18(5):379-82. PubMed ID: 21518020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
    Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
    J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
    Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
    Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the success of retrograde stenting for managing ureteral obstruction.
    Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
    J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.
    Izumi K; Mizokami A; Maeda Y; Koh E; Namiki M
    J Urol; 2011 Feb; 185(2):556-61. PubMed ID: 21168872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
    Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
    Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.
    Jeong IG; Han KS; Joung JY; Seo HK; Chung J
    BJU Int; 2007 Dec; 100(6):1288-91. PubMed ID: 17850371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of resonance metallic stents for ureteral obstruction.
    Wang HJ; Lee TY; Luo HL; Chen CH; Shen YC; Chuang YC; Chiang PH
    BJU Int; 2011 Aug; 108(3):428-32. PubMed ID: 21062397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends and Practice Patterns for Inpatient Management of Malignant Extrinsic Ureteral Obstruction in the United States.
    Haas CR; Shah O; Hyams ES
    J Endourol; 2020 Aug; 34(8):828-835. PubMed ID: 32340482
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
    Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
    BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Matsuura H; Arase S; Hori Y
    Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
    Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
    PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
    Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
    Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of metallic stents for malignant ureteral obstruction.
    Goldsmith ZG; Wang AJ; BaƱez LL; Lipkin ME; Ferrandino MN; Preminger GM; Inman BA
    J Urol; 2012 Sep; 188(3):851-5. PubMed ID: 22819410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ureteral obstruction: is the full metallic double-pigtail stent the way to go?
    Liatsikos E; Kallidonis P; Kyriazis I; Constantinidis C; Hendlin K; Stolzenburg JU; Karnabatidis D; Siablis D
    Eur Urol; 2010 Mar; 57(3):480-6. PubMed ID: 19232816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Predictive Factors of Stent Failure in the Treatment of Malignant Extrinsc Ureteral Obstruction Using Internal Ureteral Stents].
    Matsuura H; Arase S; Hori Y; Tochigi H
    Hinyokika Kiyo; 2017 Dec; 63(12):503-507. PubMed ID: 29370660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.